Investment Partners

Spinal Restoration has attracted a group of investors with broad investment experience and capital resources, as well as focused musculoskeletal market expertise. Our investment partnerships are testament to the progress achieved by Spinal Restoration and the unique investment opportunity the company represents.

Austin Ventures

With $3 billion under management across nine funds, Austin Ventures LLC has provided startup and growth capital to emerging companies for over twenty years. Austin Ventures partners with exceptionally talented entrepreneurs and operating executives to build valuable businesses in a variety of technology and service industries. The firm invests nationally but maintains a particular focus on Texas, and is the region’s most active investor. Austin Ventures’ team of investment professionals works with companies at each stage of the funding lifecycle, from initial seed investments, through startup and growth capital, to management-led buyout and recapitalizations. Austin Ventures brings a long-term investment perspective, broad experience in building high-growth companies, and access to an unparalleled network of entrepreneurs and executives.

Santé Health Ventures

Santé Health Ventures was founded in 2006 by a group of partners with deep healthcare investment and operations experience. In addition to capital, the firm provides its portfolio executives with additional healthcare domain expertise, an extensive network of relationships and singular industry focus. Santé invests exclusively in early-stage medical technology, healthcare services and healthcare IT companies.

MB Venture Partners

MB Venture Partners is based in Memphis, Tennessee and provides venture capital and strategic direction to life sciences companies. The firm invests in medical device and biotech companies at various stages of development, and is especially interested in product solutions for musculoskeletal disease. In addition to Spinal Restoration, the firm’s portfolio of healthcare investments includes GTx (NASDAQ: GTXI), BioMimetic Therapeutics (NASDAQ: BMTI), AxioMed Spine Corporation, KFx Medical, Anulex Technologies, Cayenne Medical and Applied Spine Technologies.